Providence Expands AI-Powered Genetic Screening to Detect Inherited Cancer Risks Earlier

Providence is expanding the use of artificial intelligence (AI) to identify cancer patients who may carry inherited genetic mutations, aiming to improve early detection and ensure more eligible patients receive genetic testing.

The healthcare system's Precision4ME program, now operating across three Providence hospitals in Orange County, uses AI to analyze pathology reports and flag patients who meet established guidelines for germline genetic testing. Genetic counselors then review those cases before patients are offered further assessment and testing. According to Providence, the system is designed to reduce manual review while increasing access to precision medicine.

The program recently drew attention after Laguna Niguel resident Merritt Johnson credited it with identifying an inherited Lynch syndrome mutation that ultimately led physicians to detect an early-stage stomach tumor before symptoms appeared, according to reporting by the Orange County Register.

AI Automates Case Identification for Genetic Testing

Precision4ME focuses on patients whose pathology results suggest an inherited predisposition to cancers including colorectal, breast, ovarian, pancreatic, and prostate cancer. Rather than replacing clinicians, the AI system automates the initial review of pathology reports so genetic counselors can concentrate on patient consultations and follow-up care.